In summary, we revealed previously unknown mechanisms of gliomagenesis and malignant progression driven by HMGA2 via direct activation of the transcription of the MMP2 gene, the HMGA2/GCN5 epigenetic regulation axis may provide novel targeting site in malignant glioma therapy. This evidence concerns the gene HMGA2 and malignant glioma.